54 results
8-K
EX-10.1
ITCI
Intra-Cellular Therapies Inc
9 Aug 22
Intra-cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:38am
on product liability, bodily injury, risk of bodily injury, death or property damage, infringement or misappropriation of Third Party patents, copyrights
8-K
EX-10.1
gvctby 92mv8q56djt
5 Jan 22
Financial Statements and Exhibits
4:58pm
424B5
uawbswb5 xbp2vw4
5 Jan 22
Prospectus supplement for primary offering
4:51pm
424B5
z2nlekkqdsj5u6 t52sf
3 Jan 22
Prospectus supplement for primary offering
5:30pm
424B5
5y1ab0e5zr89y8n0
11 Sep 20
Prospectus supplement for primary offering
4:44pm
424B5
ulnuj
9 Sep 20
Prospectus supplement for primary offering
4:40pm
424B5
f7d 377v91
8 Jan 20
Prospectus supplement for primary offering
5:06pm
8-K
EX-99.3
1ywxds
6 Jan 20
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
4:52pm
424B5
wbiurtvyrzek bpq7ar
6 Jan 20
Prospectus supplement for primary offering
4:42pm
S-3ASR
j9nydil 05
6 Jan 20
Automatic shelf registration
4:02pm